• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法布里病成人期的心电图变化:一项大型纵向队列研究的结果

ECG Changes during Adult Life in Fabry Disease: Results from a Large Longitudinal Cohort Study.

作者信息

El Sayed Mohamed, Postema Pieter G, Datema Mareen, van Dussen Laura, Kors Jan A, Ter Haar Cato C, Bleijendaal Hidde, Galenkamp Henrike, van den Born Bert-Jan H, Hollak Carla E M, Langeveld Mirjam

机构信息

Department of Internal Medicine, Division of Endocrinology and Metabolism, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

Amsterdam Gastroenterology Endocrinology and Metabolism, Inborn Errors of Metabolism, 1105 AZ Amsterdam, The Netherlands.

出版信息

Diagnostics (Basel). 2023 Jan 18;13(3):354. doi: 10.3390/diagnostics13030354.

DOI:10.3390/diagnostics13030354
PMID:36766461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9913957/
Abstract

Fabry disease (FD) is an X-linked, lysosomal storage disorder leading to severe cardiomyopathy in a significant proportion of patients. To identify ECG markers that reflect early cardiac involvement and disease progression, we conducted a long term retrospective study in a large cohort of FD patients. A total of 1995 ECGs from 133 patients with classical FD (64% females, 80% treated with enzyme replacement therapy), spanning 20 years of follow-up, were compared to ECGs from 3893 apparently healthy individuals. Generalized linear mixed models were used to evaluate the effect of age, FD and sex on: P-wave duration, PR-interval, QRS-duration, QTc, Cornell index, spatial QRS-T angle and frontal QRS-axis. Regression slopes and absolute values for each parameter were compared between FD patients and control subjects. At a younger age (<40 years), the Cornell index was higher and frontal QRS-axis more negative in FD patients compared to controls ( < 0.05). For the other ECG parameters, the rate of change, more than the absolute value, was greater in FD patients compared to controls ( < 0.05). From the fifth decade (men) or sixth (women) onwards, absolute values for P-wave duration, QRS-duration, QTc and spatial QRS-T angle were longer and higher in FD patients compared to control subjects. ECG abnormalities indicative of FD are age and sex dependent. Tracking the rate of change in ECG parameters could be a good way to detect disease progression, guiding treatment initiation. Moreover, monitoring ECG changes in FD can be used to evaluate the effectiveness of treatment.

摘要

法布里病(FD)是一种X连锁的溶酶体贮积症,在相当一部分患者中会导致严重的心肌病。为了确定反映早期心脏受累和疾病进展的心电图标志物,我们对一大群FD患者进行了一项长期回顾性研究。将133例经典型FD患者(64%为女性,80%接受酶替代疗法治疗)在20年随访期间的总共1995份心电图与3893名明显健康个体的心电图进行了比较。使用广义线性混合模型来评估年龄、FD和性别对以下指标的影响:P波时限、PR间期、QRS时限、QTc、康奈尔指数、空间QRS-T夹角和额面QRS轴。比较了FD患者和对照受试者之间每个参数的回归斜率和绝对值。在较年轻的年龄(<40岁),与对照组相比,FD患者的康奈尔指数更高,额面QRS轴更偏负(<0.05)。对于其他心电图参数,与对照组相比,FD患者的变化率(而非绝对值)更大(<0.05)。从第五个十年(男性)或第六个十年(女性)起,与对照受试者相比,FD患者的P波时限、QRS时限、QTc和空间QRS-T夹角的绝对值更长、更高。提示FD的心电图异常与年龄和性别有关。追踪心电图参数的变化率可能是检测疾病进展、指导开始治疗的好方法。此外,监测FD患者的心电图变化可用于评估治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c61e/9913957/4352453ef79a/diagnostics-13-00354-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c61e/9913957/8544f3f5580c/diagnostics-13-00354-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c61e/9913957/1d21b9f01854/diagnostics-13-00354-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c61e/9913957/c7c795d5ef9d/diagnostics-13-00354-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c61e/9913957/4352453ef79a/diagnostics-13-00354-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c61e/9913957/8544f3f5580c/diagnostics-13-00354-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c61e/9913957/1d21b9f01854/diagnostics-13-00354-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c61e/9913957/c7c795d5ef9d/diagnostics-13-00354-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c61e/9913957/4352453ef79a/diagnostics-13-00354-g004.jpg

相似文献

1
ECG Changes during Adult Life in Fabry Disease: Results from a Large Longitudinal Cohort Study.法布里病成人期的心电图变化:一项大型纵向队列研究的结果
Diagnostics (Basel). 2023 Jan 18;13(3):354. doi: 10.3390/diagnostics13030354.
2
The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.心电图参数作为法布里心肌病治疗反应标志物的价值。
Heart. 2016 Aug 15;102(16):1309-14. doi: 10.1136/heartjnl-2015-308897. Epub 2016 Apr 7.
3
Electrocardiographic Characteristics and Their Correlation with Echocardiographic Alterations in Fabry Disease.法布里病的心电图特征及其与超声心动图改变的相关性
J Cardiovasc Dev Dis. 2022 Jan 3;9(1):11. doi: 10.3390/jcdd9010011.
4
Characteristics of the Electrocardiogram in Japanese Fabry Patients Under Long-Term Enzyme Replacement Therapy.长期酶替代疗法下日本法布里病患者的心电图特征
Front Cardiovasc Med. 2021 Jan 14;7:614129. doi: 10.3389/fcvm.2020.614129. eCollection 2020.
5
Value of Electrocardiography to Distinguish Fabry Disease from Sarcomeric Hypertrophic Cardiomyopathy.心电图在鉴别法布里病与肌节肥厚型心肌病中的价值。
Am J Cardiol. 2022 Sep 1;178:131-136. doi: 10.1016/j.amjcard.2022.05.021. Epub 2022 Jul 6.
6
ECG-based score estimates the probability to detect Fabry Disease cardiac involvement.基于心电图的评分估计检测法布里病心脏受累的概率。
Int J Cardiol. 2021 Sep 15;339:110-117. doi: 10.1016/j.ijcard.2021.07.022. Epub 2021 Jul 16.
7
Combined Effects of Age and Comorbidities on Electrocardiographic Parameters in a Large Non-Selected Population.年龄和合并症对大型非选择性人群心电图参数的综合影响
J Clin Med. 2022 Jun 28;11(13):3737. doi: 10.3390/jcm11133737.
8
Progression of electrocardiogram changes in an untreated fabry disease: a case report.未经治疗的法布里病患者心电图变化的进展:一例报告
Eur Heart J Case Rep. 2021 Feb 20;5(2):ytab045. doi: 10.1093/ehjcr/ytab045. eCollection 2021 Feb.
9
The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.法布瑞氏病心肌表型的肥大前期和可检测存储前期。
Eur Heart J Cardiovasc Imaging. 2021 Jun 22;22(7):790-799. doi: 10.1093/ehjci/jeaa101.
10
Recognition of pre-hypertrophic cardiac involvement in Fabry Disease based on automated electrocardiographic measures.基于自动化心电图测量指标识别法布里病的心肌肥厚前期心脏受累。
Int J Cardiol. 2021 Sep 1;338:121-126. doi: 10.1016/j.ijcard.2021.06.032. Epub 2021 Jun 19.

引用本文的文献

1
A composite measurement concept for monitoring cardiac function in Fabry disease.用于监测法布里病心脏功能的复合测量概念。
Orphanet J Rare Dis. 2025 Jul 28;20(1):382. doi: 10.1186/s13023-025-03895-x.
2
Cryo-ablation management of atrial fibrillation in Fabry disease without agalsidase alpha: a case report.法布里病(无阿加糖酶α)中心房颤动的冷冻消融治疗:一例报告
Front Cardiovasc Med. 2025 May 30;12:1483283. doi: 10.3389/fcvm.2025.1483283. eCollection 2025.
3
Applying artificial intelligence to rare diseases: a literature review highlighting lessons from Fabry disease.

本文引用的文献

1
Early start of enzyme replacement therapy in pediatric male patients with classical Fabry disease is associated with attenuated disease progression.早期开始酶替代疗法可减缓经典型 Fabry 病男性患儿的疾病进展。
Mol Genet Metab. 2022 Feb;135(2):163-169. doi: 10.1016/j.ymgme.2021.12.004. Epub 2021 Dec 17.
2
Fabry Disease and the Heart: A Comprehensive Review.《法布瑞病与心脏:全面综述》。
Int J Mol Sci. 2021 Apr 23;22(9):4434. doi: 10.3390/ijms22094434.
3
Influence of sex and phenotype on cardiac outcomes in patients with Fabry disease.
将人工智能应用于罕见病:一项以法布里病为例的文献综述
Orphanet J Rare Dis. 2025 Apr 17;20(1):186. doi: 10.1186/s13023-025-03655-x.
4
2024 Update of the TSOC Expert Consensus of Fabry Disease.《法布里病TSOC专家共识2024年更新》
Acta Cardiol Sin. 2024 Sep;40(5):544-568. doi: 10.6515/ACS.202409_40(5).20240731A.
5
Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking.安德森-法布里病的心电图分析:用于进行性表型表达追踪的宝贵工具。
Front Cardiovasc Med. 2023 Jun 21;10:1184361. doi: 10.3389/fcvm.2023.1184361. eCollection 2023.
6
Increased cardiac involvement in Fabry disease using blood-corrected native T1 mapping.应用血液校正的心肌 native T1 mapping 技术检测法布雷病的心脏受累。
Sci Rep. 2023 Mar 17;13(1):4420. doi: 10.1038/s41598-023-31211-9.
性别和表型对法布瑞氏病患者心脏结局的影响。
Heart. 2021 Dec;107(23):1889-1897. doi: 10.1136/heartjnl-2020-317922. Epub 2021 Feb 10.
4
Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy.用于鉴别安德森-法布里病和肥厚型心肌病的标准心电图
Heart. 2022 Jan;108(1):54-60. doi: 10.1136/heartjnl-2020-318271. Epub 2021 Feb 9.
5
Characteristics of the Electrocardiogram in Japanese Fabry Patients Under Long-Term Enzyme Replacement Therapy.长期酶替代疗法下日本法布里病患者的心电图特征
Front Cardiovasc Med. 2021 Jan 14;7:614129. doi: 10.3389/fcvm.2020.614129. eCollection 2020.
6
The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.法布瑞氏病心肌表型的肥大前期和可检测存储前期。
Eur Heart J Cardiovasc Imaging. 2021 Jun 22;22(7):790-799. doi: 10.1093/ehjci/jeaa101.
7
Altered Sphingolipids Metabolism Damaged Mitochondrial Functions: Lessons Learned From Gaucher and Fabry Diseases.鞘脂代谢改变损害线粒体功能:从戈谢病和法布里病中吸取的教训。
J Clin Med. 2020 Apr 14;9(4):1116. doi: 10.3390/jcm9041116.
8
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts.酶替代疗法对男性法布里病患者临床结局的影响:欧洲专家小组的系统文献综述
Mol Genet Metab Rep. 2019 Feb 6;19:100454. doi: 10.1016/j.ymgmr.2019.100454. eCollection 2019 Jun.
9
Incremental diagnostic and prognostic value of the QRS-T angle, a 12-lead ECG marker quantifying heterogeneity of depolarization and repolarization, in patients with suspected non-ST-elevation myocardial infarction.QRS-T 角作为一种 12 导联心电图标记物,可量化去极化和复极化的不均一性,对疑似非 ST 段抬高型心肌梗死患者具有渐进式的诊断和预后价值。
Int J Cardiol. 2019 Feb 15;277:8-15. doi: 10.1016/j.ijcard.2018.09.040. Epub 2018 Sep 19.
10
Cardiac Phenotype of Prehypertrophic Fabry Disease.肥厚型 Fabry 病的心脏表型。
Circ Cardiovasc Imaging. 2018 Jun;11(6):e007168. doi: 10.1161/CIRCIMAGING.117.007168.